Literature DB >> 16377081

L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells.

Alexander Stoeck1, Sabine Schlich, Yasmin Issa, Verena Gschwend, Till Wenger, Ingrid Herr, Alexander Marmé, Sarah Bourbie, Peter Altevogt, Paul Gutwein.   

Abstract

The progression of ovarian cancer is driven by a variety of cellular factors that are incompletely understood. Binding of tumor cells to normal cells and to soluble factors influence tumor growth, angiogenesis and the stimulation of vascular permeability leading to ascites production. L1 adhesion molecule is overexpressed in ovarian carcinoma and is associated with bad prognosis. One receptor for L1 is Neuropilin-1 (NRP-1) that is also known as a receptor for VEGF(165). In the nervous system a complex of NRP-1 and L1 transmits signals by the neurorepellant Sem3A that is critical for the control of neurite outgrowth. NRP-1 has also been detected in human carcinomas but its function remains unknown. Here, we have examined NRP-1 expression in ovarian carcinoma cell lines and tissue. We report that little NRP-1 protein was detected in primary ovarian carcinoma tissues or established cell lines although mRNA for soluble and transmembrane NRP-1 were detected by RT-PCR. Instead, we observed strong expression of NRP-1 in mesothelial cells, which form the lining of the peritoneum. NRP-1 could serve as an isolation marker for primary mesothelial cells present in ascites fluid. We demonstrate that ovarian cancer cells expressing L1 can bind to NRP-1 overexpressing cells and mesothelial cells. Likewise, soluble L1 isolated from ascites of patients or produced as a fusion protein could bind to NRP-1 overexpressing cells and a direct interaction was demonstrated at the protein level. These findings suggest that L1 can support the binding of ovarian carcinoma cells to mesothelial cells via NRP-1. The L1-NRP-1 binding pathway could contribute to the growth of ovarian carcinomas and to reciprocal signalling between mesothelial cells and tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377081     DOI: 10.1016/j.canlet.2005.08.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

Authors:  Juliette O A M van Baal; Cornelis J F van Noorden; Rienk Nieuwland; Koen K Van de Vijver; Auguste Sturk; Willemien J van Driel; Gemma G Kenter; Christianne A R Lok
Journal:  J Histochem Cytochem       Date:  2017-11-22       Impact factor: 2.479

Review 2.  L1CAM malfunction in the nervous system and human carcinomas.

Authors:  Michael K E Schäfer; Peter Altevogt
Journal:  Cell Mol Life Sci       Date:  2010-03-17       Impact factor: 9.261

3.  Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.

Authors:  Sirin A I Adham; Ifat Sher; Brenda L Coomber
Journal:  Lab Invest       Date:  2010-03-01       Impact factor: 5.662

4.  Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity.

Authors:  Svenja Riedle; Helena Kiefel; Daniela Gast; Sandra Bondong; Silke Wolterink; Paul Gutwein; Peter Altevogt
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

5.  L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression.

Authors:  Evelin Grage-Griebenow; Elfi Jerg; Artur Gorys; Daniel Wicklein; Daniela Wesch; Sandra Freitag-Wolf; Lisa Goebel; Ilka Vogel; Thomas Becker; Michael Ebsen; Christoph Röcken; Peter Altevogt; Udo Schumacher; Heiner Schäfer; Susanne Sebens
Journal:  Mol Oncol       Date:  2014-04-02       Impact factor: 6.603

6.  Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration.

Authors:  Yasmin Issa; Daniel Nummer; Tobias Seibel; Susanne Sebens Müerköster; Moritz Koch; Friedrich-Hubertus Schmitz-Winnenthal; Luis Galindo; Juergen Weitz; Philipp Beckhove; Peter Altevogt
Journal:  J Mol Med (Berl)       Date:  2008-10-18       Impact factor: 4.599

Review 7.  Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma.

Authors:  Juan Chen; Li Fu; Li-Yi Zhang; Dora L Kwong; Li Yan; Xin-Yuan Guan
Journal:  Chin J Cancer       Date:  2012-02-24

8.  Differential expression of CHL1 gene during development of major human cancers.

Authors:  Vera N Senchenko; George S Krasnov; Alexey A Dmitriev; Anna V Kudryavtseva; Ekaterina A Anedchenko; Eleonora A Braga; Irina V Pronina; Tatiana T Kondratieva; Sergey V Ivanov; Eugene R Zabarovsky; Michael I Lerman
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

Review 9.  Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma.

Authors:  Maria V Barbolina
Journal:  Cancers (Basel)       Date:  2018-11-15       Impact factor: 6.639

Review 10.  Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options.

Authors:  Nina Sluiter; Erienne de Cuba; Riom Kwakman; Geert Kazemier; Gerrit Meijer; Elisabeth Atie Te Velde
Journal:  Clin Exp Metastasis       Date:  2016-04-13       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.